Study design and population
noncirrhotic NASH
NASH-CHECK was included in an international phase 2, randomized, placebo-controlled, double-blind study (FLIGHT-FXR; NCT02855164) designed to assess the safety, tolerability, and efficacy of tropifexor in adult patients with noncirrhotic NASH [